Profile: Abbott India Ltd (ABOT.NS)
ABOT.NS on National Stock Exchange of India
1,450.40INR
7:08am EDT
1,450.40INR
7:08am EDT
Price Change (% chg)
Rs9.85 (+0.68%)
Rs9.85 (+0.68%)
Prev Close
Rs1,450.45
Rs1,450.45
Open
Rs1,427.05
Rs1,427.05
Day's High
Rs1,456.00
Rs1,456.00
Day's Low
Rs1,420.00
Rs1,420.00
Volume
1,698
1,698
Avg. Vol
3,756
3,756
52-wk High
Rs1,629.90
Rs1,629.90
52-wk Low
Rs1,251.00
Rs1,251.00
Abbott India Limited is a pharmaceutical company engaged in the discovery, development, manufacture and marketing of pharmaceutical, nutritional, hospital, and diagnostic products. It has four divisions. The Primary Care division markets products in the areas of pain management and gastroenterology. The Specialty Care-Methabolics and Urology division provides solutions in the areas of thyroid, obesity, diabetes and benign prostatic hyperplasia. Hospital Care offers products in the field of anesthesiology and neonatology, such as Forane, Sevorane and Survanta. The Super Specialty Care division provides products in the therapy area of liver care. Its Primary Care products include Brufen, Cremaffin, Surbex, Ganaton and Brugel. Its Hospital Care products include Sevorane / Sevoflurane, Forane, Survanta and Anetol IV. Its Specialty Care products include Thyrocab, Thyrowel, Thyronorm and Triobimet. During the fiscal year ending December 31, 2010, the Company acquired Solvay Pharmaceuticals.
Company Address
Abbott India Ltd
3-4 Corporate Park
Sion-Trombay Road, Chembur
MUMBAI 400071
P: +9122.67978888
F: +9122.67978920
Company Web Links
| Name | Compensation |
|---|---|
Munir Ahmed Shaikh |
-- |
R. Sonalker |
-- |
Krupa Anandpara |
-- |
Rehan Khan |
-- |
Kaiyomarz Marfatia |
5,596,060 |

